Zobrazeno 1 - 5
of 5
pro vyhledávání: '"P. Huw Roddie"'
Autor:
Gashirai K. Mbizvo, Isabel C. Lentell, Clifford Leen, Huw Roddie, Christopher P. Derry, Susan E. Duncan, Kristiina Rannikmäe
Publikováno v:
Journal of Medical Case Reports, Vol 13, Iss 1, Pp 1-9 (2019)
Abstract Background We describe a patient copresenting with epilepsia partialis continua, tuberculosis, and hemophagocytic lymphohistiocytosis. To our knowledge, this is the first documented case of this triad. Case presentation A 54-year-old black S
Externí odkaz:
https://doaj.org/article/8b7098fea93247c998152b8075479a09
Autor:
Meletios A. Dimopoulos, Robert Z. Orlowski, Thierry Facon, Pieter Sonneveld, Kenneth C. Anderson, Meral Beksac, Lotfi Benboubker, Huw Roddie, Anna Potamianou, Catherine Couturier, Huaibao Feng, Ozlem Ataman, Helgi van de Velde, Paul G. Richardson
Publikováno v:
Haematologica, Vol 100, Iss 1 (2015)
Bortezomib-dexamethasone is widely used for relapsed myeloma in routine clinical practice, but comparative data versus single-agent bortezomib are lacking. This retrospective analysis compared second-line treatment with bortezomib-dexamethasone and b
Externí odkaz:
https://doaj.org/article/57dbabfd99fe4bf29ee120b9b810e5be
Autor:
Meletios A. Dimopoulos, Meral Beksac, Lotfi Benboubker, Huw Roddie, Nathalie Allietta, Esther Broer, Catherine Couturier, Marie-Andrée Mazier, Ralf Angermund, Thierry Facon
Publikováno v:
Haematologica, Vol 98, Iss 8 (2013)
This phase II study is the first prospective evaluation of bortezomib-dexamethasone as second-line therapy for relapsed/refractory multiple myeloma. A total of 163 patients were enrolled to receive four cycles of bortezomib-dexamethasone. Patients we
Externí odkaz:
https://doaj.org/article/9f2370cb603d4568863e404a286057f1
Publikováno v:
Storrar, N, Mathur, A, Johnson, P & Roddie, H 2018, ' Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide-and lenalidomide-containing regimens ', British journal of haematology . https://doi.org/10.1111/bjh.15392
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5228deed37b6a294addc6acce3716b30
https://pubmed.ncbi.nlm.nih.gov/29785771
https://pubmed.ncbi.nlm.nih.gov/29785771
Autor:
Graham McKillop, A. John Simpson, Jennifer M.J. Richards, Carol Bienek, Scott Ian Kay Semple, P. Huw Roddie, William A Wallace, G. Robin Barclay, Ninian N. Lang, Anne P.M. Atkinson, Marc Turner, Tom MacGillivray, Shirjel Alam, David E. Newby, Adam T. Hill, K. Dhaliwal, Catherine A Shaw, Nicholas L. Mills, Giora Z. Feuerstein, Thomas A. Connolly, Anne Burdess, Elaine K. Forrest, Julie H. Crawford, Calum Gray, Michelle C. Williams
Publikováno v:
Circulation. Cardiovascular imaging. 5(4)
Background— Cell therapy is an emerging and exciting novel treatment option for cardiovascular disease that relies on the delivery of functional cells to their target site. Monitoring and tracking cells to ensure tissue delivery and engraftment is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8465b5e23925a8521a97c25cc168b16
https://pubmed.ncbi.nlm.nih.gov/22787016
https://pubmed.ncbi.nlm.nih.gov/22787016